Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

User Fee Discussions Include Funding Parts Of FDA Regulatory Science Plan

Oct 25 2010

• By Derrick Gingery

Related Content

Biomarker Guidance To Encompass More Than Biomarkers, FDA Says

Jun 21 2010

Antibiotic Development: FDA Says New Guidances Will Help, But Industry Questions Statistical Focus

Jun 28 2010

PDUFA Negotiations: FDA Wants To Be Able To Call "Time-Out" During Reviews

Oct 25 2010

FDA Has Regulatory Science Plan; Now It Needs Funding

Oct 06 2010

Hamburg Outlines The Potential Of Regulatory Science Investment

Oct 11 2010

FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less

Aug 02 2010

Advanced Life Sciences To Pursue New Countermeasure Fund

Aug 24 2010

Orphan Drug Reviews: Industry Wants FDA To Move Out Of Its Comfort Zone

Jul 05 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window